Dartmouth Study: Low-Dose CT Can be Cost-Effective in Lung Cancer Screening

Researchers from Dartmouth, Hanover, NH, say lung cancer screening in the National Lung Screening Trial (NLST) meets a commonly accepted standard for cost effectiveness as reported in the November 6 issue of the New England Journal of Medicine. This relatively new screening test uses annual low-dose CT scans to spot lung tumors early in individuals facing the highest risks of lung cancer due to age and smoking history.

[Source: Dartmouth-Hitchcock]